Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Following Cytoreduction With Chemotherapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00377104
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:28.748971+00:00
Published At
2013-07-02T00:00:00+00:00
Record Updated At
2013-07-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["B-cell Chronic Lymphocytic Leukemia", "Contiguous Stage II Small Lymphocytic Lymphoma", "Noncontiguous Stage II Small Lymphocytic Lymphoma", "Stage I Chronic Lymphocytic Leukemia", "Stage I Small Lymphocytic Lymphoma", "Stage II Chronic Lymphocytic Leukemia", "Stage III Chronic Lymphocytic Leukemia", "Stage III Small Lymphocytic Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Small Lymphocytic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-07-02"
protocolSection.identificationModule.nctId
"NCT00377104"
protocolSection.identificationModule.officialTitle
"A Phase I Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Following Cytoreduction With Chemotherapy"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • B-cell Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage IV Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.